Terminated NA INTERVENTIONAL NCT00519181

Safety and Efficiency Study of Valproic Acid In HAM/TSP (VALPROHAM)

Open Label Study of the Clinical and Laboratory Effects of Valproic Acid In HAM/TSP

Sponsor: University Hospital Pierre Zobda-Quitman

Updated 5 times since 2017 Last updated: Aug 20, 2007 Started: Mar 31, 2006 Completion: Jun 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

A NA clinical study on HTLV-I-Associated Myelopathy, this trial is terminated or withdrawn. The trial is conducted by University Hospital Pierre Zobda-Quitman and has accumulated 5 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Mar 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital Pierre Zobda-Quitman

Data source: University Hospital Pierre Zobda-Quitman

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.